Filter Results:
(3,187)
Show Results For
- All HBS Web
(3,187)
- People (7)
- News (425)
- Research (2,389)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,965)
Show Results For
- All HBS Web
(3,187)
- People (7)
- News (425)
- Research (2,389)
- Events (1)
- Multimedia (5)
- Faculty Publications (1,965)
- 12 Feb 2016
- Op-Ed
The Real Jobs Tragedy in the US: We've Lost the Skills
States economy maintained a steady pace in job growth of about 2 percent a year. The US labor force participation rate reflected that, growing robustly for the four decades from 1947 to 1997. Around 2001, both those indicators of the View Details
- August 2008 (Revised September 2008)
- Case
The Flaxil Label (A)
This case focuses on the 2001 negotiation between Mytex Pharmaceuticals and the U.S. Food and Drug Administration (FDA). The outcome of the negotiation would determine the new label for Mytex's blockbuster drug for arthritis, Flaxil. The negotiation is quite... View Details
Keywords: Governing Rules, Regulations, and Reforms; Health Disorders; Product Launch; Negotiation Process; Business and Government Relations; Safety; Pharmaceutical Industry
Barron, Greg M. "The Flaxil Label (A)." Harvard Business School Case 909-001, August 2008. (Revised September 2008.)
- April 1995 (Revised August 1995)
- Supplement
Empire Blue Cross and Blue Shield (F)
By: Regina E. Herzlinger and Ramona Hilgenkamp
Supplements the (A) case. View Details
Herzlinger, Regina E., and Ramona Hilgenkamp. "Empire Blue Cross and Blue Shield (F)." Harvard Business School Supplement 195-221, April 1995. (Revised August 1995.)
- July 2014
- Teaching Note
Vaxess Technologies, Inc.
By: John A. Quelch
- October 2012
- Supplement
Olympus (B)
By: Jay W. Lorsch, Suraj Srinivasan and Kathleen Durante
This case outlines Michael Woodford's awards and honors, after having been fired from Olympus in October 2011. It discusses the repercussions following an investigation into the fraud and the report that was released thereafter. It also discusses the lawsuit that... View Details
Lorsch, Jay W., Suraj Srinivasan, and Kathleen Durante. "Olympus (B) ." Harvard Business School Supplement 413-075, October 2012.
- November 2011 (Revised February 2012)
- Case
China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise
By: Vicki Sato, Christoph Jaeker and Pooja Mehta Solanki
As the head of the Novartis Institute for Biomedical Research in China, En Li was shepherding a $1 billion R&D investment in China. So far he had been able to attract a large number of Chinese-born but US-trained scientists to play a critical role in establishing the... View Details
Keywords: Globalized Firms and Management; Research; Corporate Strategy; Pharmaceutical Industry; Pharmaceutical Industry; China
Sato, Vicki, Christoph Jaeker, and Pooja Mehta Solanki. "China Novartis Institute for Biomedical Research: Building a Sustainable, Globally Integrated Research Enterprise." Harvard Business School Case 612-048, November 2011. (Revised February 2012.)
- December 2010
- Supplement
Urban Water Partners (A) Spreadsheet Solutions (CW)
By: Karthik Ramanna and George Serafeim
Teaching Note for Spreadsheet (111701). View Details
- December 2010
- Teaching Note
Roche's Acquisition of Genentech (TN)
By: Bo Becker and Carliss Y. Baldwin
Teaching Note for 210-040. View Details
- April 2010
- Teaching Note
Wyeth Pharmaceuticals: Spurring Scientific Creativity with Metrics
Teaching Note for [607008]. View Details
- March 2009
- Teaching Note
Proteus Biomedical: Making Pigs Fly (TN)
Teaching Note for [809051]. View Details
- November 2007 (Revised August 2014)
- Case
D2Hawkeye: Growing the Medical IT Enterprise
By: Robert F. Higgins, Rosie O'Donnell, Sophie LaMontagne and Brent Kazan
In mid-March 2007, Chris Kryder sat in his office and thought about how to best finance his company's growth. Over the previous five years as founder and CEO of D2Hawkeye, a Waltham, Massachusetts-based healthcare analytics company, Kryder had grown the firm from a... View Details
Keywords: Strategy Development; Strategic Positioning; Strategic Vision; Venture Capital; Small Business; Investment; Growth Management; Expansion; Business Growth and Maturation; Decision Choices and Conditions; Financing and Loans; Business Startups; Financial Strategy; Business Strategy; Service Industry; Service Industry; Waltham
Higgins, Robert F., Rosie O'Donnell, Sophie LaMontagne, and Brent Kazan. "D2Hawkeye: Growing the Medical IT Enterprise." Harvard Business School Case 808-006, November 2007. (Revised August 2014.)
- December 2005 (Revised May 2007)
- Case
Cynthia Fisher and the Rearing of ViaCell
By: Robert F. Higgins, Richard G. Hamermesh and Ingrid Vargas
Describes the start up of Viacord, a Boston-based medical services firm founded by Cynthia Fisher (HBS MBA) in 1993. Told from Fisher's perspective, the entrepreneur details the conceptualization and launch of the business and the many obstacles and expenses faced in... View Details
Keywords: Managerial Roles; Business Growth and Maturation; Entrepreneurship; Business Startups; Service Industry; Service Industry; Boston
Higgins, Robert F., Richard G. Hamermesh, and Ingrid Vargas. "Cynthia Fisher and the Rearing of ViaCell." Harvard Business School Case 806-002, December 2005. (Revised May 2007.)
- April 2000
- Teaching Note
Patient Care Delivery Model at the Massachusetts General Hospital, The TN
By: Amy C. Edmondson, Richard M.J. Bohmer and Emily Heaphy
Teaching Note for (9-699-154). View Details
- July 1985 (Revised January 1988)
- Case
American Hospital Supply Corp.: The ASAP System (A)
American Hospital Supply, the largest firm in the U.S. hospital supply industry, has achieved success in part through the use of information systems. Changes in the hospital marketplace suggest a shift in strategy would be appropriate. What role should information... View Details
Keywords: Information Technology; Order Taking and Fulfillment; Distribution Industry; Distribution Industry; United States
Vitale, Michael R. "American Hospital Supply Corp.: The ASAP System (A)." Harvard Business School Case 186-005, July 1985. (Revised January 1988.)
- April 1975 (Revised November 1987)
- Case
Medibus, Inc.
By: W. Earl Sasser
Sasser, W. Earl. "Medibus, Inc." Harvard Business School Case 675-177, April 1975. (Revised November 1987.)
- 01 Jun 2008
- News
Kash Rangan
being that more money can then go to actual programs. So an organization might report, “We spend 6 percent on fundraising, whereas the industry average is 12 to 14 percent.” That’s typical, but beyond that, we don’t know how the other 94... View Details
- October 2010 (Revised November 2010)
- Background Note
Plavix: Drugs in the Age of Personalized Medicine
By: Richard G. Hamermesh, Mara G. Aspinall and Rachel Gordon
PIavix, one of the world's best selling drugs in 2010, appears to have a limited future. Its patent was due to expire soon, and recently new data had been discovered that indicated that a small subset of the population would be at risk for stroke, heart attack, or even... View Details
Keywords: Health Care and Treatment; Product Positioning; Business and Government Relations; Genetics; Competitive Strategy; Pharmaceutical Industry
Hamermesh, Richard G., Mara G. Aspinall, and Rachel Gordon. "Plavix: Drugs in the Age of Personalized Medicine." Harvard Business School Background Note 811-001, October 2010. (Revised November 2010.)
- January 2009
- Case
When Supply is of Public Interest: Roche & Tamiflu
The case focuses on the challenges of Roche maintaining a supply network for a global influenza pandemic response initiative based on its antiviral drug Tamiflu. The Roche group is a 40 billion CHF company consisting of a pharmaceutical division and a diagnostic... View Details
Keywords: Global Strategy; Health Pandemics; Distribution; Logistics; Production; Supply Chain Management; Performance Capacity; Pharmaceutical Industry
Watson, Noel H., Laura Rock Kopczak, and Prashant Yadav. "When Supply is of Public Interest: Roche & Tamiflu." Harvard Business School Case 609-061, January 2009.
- July 1994 (Revised March 1996)
- Case
Baxter International: OnCall as Soon as Possible?
Baxter Healthcare is heir to the fabled ASAP ordering system, one of the best-known examples of the use of technology to provide strategic marketing advantage. By 1994, the proprietary ASAP system is well established. Baxter is beginning to launch On-Call EDI, which is... View Details
Keywords: Information Technology; Competitive Advantage; Business Strategy; Information Technology Industry; Information Technology Industry
Sviokla, John J., and Chris L Marshall. "Baxter International: OnCall as Soon as Possible?" Harvard Business School Case 195-103, July 1994. (Revised March 1996.)
- April 1993
- Teaching Note
Becton Dickinson Division: Marketing Organization TN
By: Frank V. Cespedes
Teaching Note for (9-593-070). View Details